Pharma Foods International Co., Ltd. (TYO:2929)
691.00
-1.00 (-0.14%)
Sep 14, 2026, 3:30 PM JST
TYO:2929 Financials Overview
Financials in millions JPY. Fiscal year is August - July.
Millions JPY. Fiscal year is Aug - Jul.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Jul '26 Jul 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
Revenue Revenue Growth | 63,223 | 63,223 | 65,260 | 62,147 | 68,572 | 60,185 |
Revenue Growth | -3.12% | -3.12% | 5.01% | -9.37% | 13.94% | 28.73% |
Gross Profit Gross Profit Growth | 50,693 | 50,693 | 52,584 | 48,752 | 55,279 | 48,108 |
Operating Income Operating Income Growth | 2,633 | 2,633 | 2,369 | 5,114 | 3,610 | 1,080 |
Net Income Net Income Growth | 1,988 | 1,988 | 368 | 3,205 | 3,081 | -374 |
Earnings Per Share EPS Growth | 68.60 | 68.60 | 12.80 | 112.69 | 106.70 | -12.89 |
EPS Growth | 435.82% | 435.82% | -88.64% | 5.62% | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
B to C Business B to C Business Growth | 56,730 | 52,543 | 59,788 | 51,886 |
Other Other Growth | 15 | 16 | 21 | - |
Bio Medical Business Bio Medical Business Growth | 331 | 478 | 343 | 220 |
B to B Business B to B Business Growth | 8,182 | 9,108 | 8,418 | 8,079 |
Total Total Growth | 65,258 | 62,145 | 68,570 | 60,185 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Jul '26 Jul 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
Cash & Investments Cash & Investments Growth | 7,791 | 7,791 | 9,157 | 15,666 | 16,306 | 8,845 |
Total Debt Total Debt Growth | 17,171 | 17,171 | 12,631 | 16,891 | 20,096 | 16,857 |
Net Cash (Debt) Net Cash Growth | -9,380 | -9,380 | -3,474 | -1,225 | -3,790 | -8,012 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -323.69 | -323.69 | -120.87 | -43.07 | -131.25 | -276.14 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Jul '26 Jul 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | - | -1,092 | 5,486 | 6,125 | -6,065 |
Capital Expenditures CapEx Growth | - | - | -891 | -841 | -386 | -467 |
Free Cash Flow Free Cash Flow Growth | - | - | -1,983 | 4,645 | 5,739 | -6,532 |
Free Cash Flow Growth | - | - | - | -19.06% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Jul '26 Jul 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
Gross Margin | 80.18% | 80.18% | 80.58% | 78.45% | 80.62% | 79.93% |
Operating Margin | 4.17% | 4.17% | 3.63% | 8.23% | 5.27% | 1.79% |
Pretax Margin | 3.68% | 3.68% | 3.73% | 8.10% | 5.17% | 2.36% |
Profit Margin | 3.14% | 3.14% | 0.56% | 5.16% | 4.49% | -0.62% |
FCF Margin | - | - | -3.04% | 7.47% | 8.37% | -10.85% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Jul '26 Jul 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 25.000 | - | 25.000 | 25.000 | 22.000 | 20.000 |
Dividend Per Share Growth | 0% | - | 0% | 13.64% | 10.00% | 0% |
Dividend Yield | 3.61% | - | 2.93% | 2.43% | 1.44% | 1.52% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Jul '26 Jul 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 |
PE Ratio | 10.09 | 8.15 | 69.60 | 9.64 | 15.69 | - |
Forward PE | 12.72 | 10.52 | - | - | - | - |
P/FCF Ratio | - | - | - | 6.65 | 8.42 | - |
PS Ratio | 0.32 | 0.26 | 0.39 | 0.50 | 0.71 | 0.71 |